Jaguar Health Exchanges Preferred Stock for Common Stock
Jaguar Health, Inc. (JAGX) announced two privately negotiated exchange agreements with Streeterville Capital, LLC. In the first agreement on May 26, 2026, the company issued 31,958 shares of common stock in exchange for 3.72 shares of Series Q Preferred Stock. In the second agreement on June 1, 2026, the company issued 32,710 shares of common stock in exchange for 4.2 shares of Series Q Preferred Stock. These exchanges were made in reliance on an exemption from registration under the Securities Act. Additionally, the company reconvened its 2026 Annual Meeting of Stockholders on June 2, 2026, and further adjourned it to June 8, 2026, to allow stockholders more time to review supplemental proxy materials.
Key Highlights
- Jaguar Health exchanged 3.72 shares of Series Q Preferred Stock for 31,958 shares of Common Stock with Streeterville Capital.
- Jaguar Health exchanged 4.2 shares of Series Q Preferred Stock for 32,710 shares of Common Stock with Streeterville Capital.
- The company reconvened its 2026 Annual Meeting of Stockholders on June 2, 2026, and adjourned it again until June 8, 2026.
- The exchange transactions were conducted under Section 3(a)(9) of the Securities Act of 1933, exempting them from registration.
Price Impact
More from JAGX